BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH ·Technology, Scientific & Technical Instruments, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017
Operating Activities
Net Income $-31.3K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-25.9K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities
Net Change in Cash
Free Cash Flow
← Newer Page 2 of 2 Older →